Tigerless Health to Go Public via \$280 Million SPAC Deal with Piermont Valley Acquisition Corp.

Key Highlights

• Business Combination Announcement: Tigerless Health, Inc., a New York-based Insurtech company, has entered into a definitive agreement to merge with Piermont Valley Acquisition Corp. (OTCID: CMCAF), a special purpose acquisition company (SPAC), paving the way for Tigerless Health to become a publicly traded entity.
• Valuation: The transaction values Tigerless Health at an enterprise value of approximately \$280 million.
• NASDAQ Listing: Upon closing, the combined company is expected to be renamed “Tigerless AI Holdings, Inc.” and listed on NASDAQ, providing Tigerless Health with enhanced visibility and access to public capital markets.
• Shareholder Structure: Existing Tigerless Health shareholders will roll 100% of their equity into the combined company, signaling strong confidence in the future of the firm.
• Leadership Continuity: The current management team, led by founder and CEO Zikang Wu, will continue to lead the combined company after the transaction closes.
• Strategic Focus: The capital infusion from the SPAC merger is intended to accelerate Tigerless Health’s investment in proprietary artificial intelligence (AI) technology aimed at simplifying and improving how consumers access, understand, and manage insurance.
• Transaction Timing: The deal is expected to close in the second half of 2026, subject to required regulatory and shareholder approvals and other customary closing conditions.

In-Depth Company Overview

Founded in 2018 and headquartered in New York City, Tigerless Health, Inc. is an Insurtech company focused on transforming the consumer insurance experience. The company leverages a modern, data-driven platform to make it easier for consumers to find, compare, and manage insurance coverage tailored to their needs.

The U.S. insurance market, one of the world’s largest, is characterized by complexity and opacity, with consumers often struggling to compare plans, understand benefits, and secure suitable coverage. Tigerless Health aims to disrupt this status quo by using proprietary AI technologies to close the gap between consumers and the coverage they require. The company’s platform aspires to offer clarity, guidance, and personalization previously accessible only to industry insiders.

Tigerless Health’s vision is to democratize access to insurance information and enhance the overall consumer experience throughout the insurance lifecycle—from policy selection to claims management—by leveraging AI to deliver insights and recommendations to all users, regardless of background or expertise.

Transaction Details

• The enterprise value of Tigerless Health in the deal is approximately \$280 million.
• All existing shareholders of Tigerless Health will roll their equity into the new publicly traded company, ensuring alignment of interests among current owners and new investors.
• The transaction is designed to support Tigerless Health’s continued investment in technology, especially AI capabilities that enhance the insurance navigation experience for consumers.
• The Boards of Directors of both Tigerless Health and PVAC have unanimously approved the transaction.
• Closing is anticipated in the second half of 2026, pending regulatory and shareholder approvals and other customary conditions.
• Legal advisors for the transaction are Edelman Legal Consulting PLLC (PVAC) and Graubard Miller (Tigerless Health).

Management Remarks

Zikang Wu, Founder and CEO of Tigerless Health, Inc.:
“We founded Tigerless Health because we believed that navigating insurance should not require expertise, connections, or luck — it should be simple, transparent, and accessible to everyone. This business combination with Piermont Valley Acquisition Corp. is an important milestone on that journey, and we expect that it will provide us with the resources to go further and faster than ever before. I am grateful to our team, our partners, and every customer who has trusted us to help them make sense of one of the most important decisions in their lives. We are just getting started, and I could not be more excited about what comes next.”

Wei Qian, CEO of Piermont Valley Acquisition Corp.:
“From the moment we engaged with Tigerless Health, it was clear that this team has identified a compelling and underserved opportunity and is building the right technology to capture it. We have tremendous confidence in Zikang and his team, and we are excited to support them as they take this next bold step forward.”

What Shareholders Need to Know

• Potential for Share Price Movement: The announcement of the business combination and public listing is a material event that may impact the share price of both Tigerless Health (upon listing as Tigerless AI Holdings, Inc.) and Piermont Valley Acquisition Corp. (CMCAF) in the lead-up to and following the transaction.
• Regulatory and Shareholder Approvals: The deal remains subject to regulatory, shareholder, and other customary approvals. Delays, additional conditions, or failure to close could materially impact the transaction and associated share values.
• Lock-Up and Dilution: While existing Tigerless Health shareholders will roll all their equity, the specifics of any lock-up arrangements, dilution from the transaction, and details of the share structure post-merger will be important for investors to review in the forthcoming proxy/registration statement.
• Growth Strategy and AI Investment: The capital from the transaction will be used to accelerate development of Tigerless Health’s AI-driven insurance platform. Execution risk, technology adoption, and the company’s ability to scale will be key drivers of future performance and share value.
• SEC Filings: Investors and shareholders are urged to review the full proxy/prospectus and registration statement when filed with the SEC, as it will contain comprehensive details about the transaction, associated risks, and the future business plan.
• Forward-Looking Statements: The press release contains forward-looking statements subject to various risks, including completion of the transaction, integration challenges, regulatory hurdles, market conditions, and the ability to execute strategic objectives. Actual results may differ materially from those projected.

Next Steps

Investors and shareholders are encouraged to:

• Monitor SEC filings, including the forthcoming registration statement and proxy materials, for further updates and disclosures related to the transaction.
• Review risk factors and business updates as they become available to make informed investment decisions.
• Direct inquiries to Tigerless Health ([email protected]) or Piermont Valley Acquisition Corp. ([email protected]) for additional investor relations information.

About Tigerless Health, Inc.

Tigerless Health, founded in 2018 and based in New York City, is an Insurtech firm developing AI-driven digital solutions to transform how consumers access, understand, and utilize insurance coverage.

About Piermont Valley Acquisition Corp.

Piermont Valley Acquisition Corp. is a blank check company formed to effect mergers, asset acquisitions, stock purchases, reorganizations, or similar business combinations with one or more businesses. PVAC completed its initial public offering in December 2021.

Disclaimer

This article contains forward-looking statements based on current expectations, projections, and information available as of the date of publication. Actual results may differ materially due to risks and uncertainties related to the proposed business combination, regulatory approvals, market conditions, and other factors. Investors are urged to review official filings with the SEC and consult with their financial advisors before making investment decisions. This article does not constitute an offer to sell or a solicitation of an offer to buy any securities.

View Piermont Valley Acquisition Corp Historical chart here